Success Metrics

Completion Rate

0%(0/1)

Active Trials

2(50%)

Terminated

1(25%)

Phase Distribution

Ph phase_2

25%

Ph phase_3

25%

Ph phase_4

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

Phase 3Large-scale testing

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Terminated(1)

Detailed Status

Recruiting2

Enrolling by invitation1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (33.3%)

Phase 31 (33.3%)

Phase 41 (33.3%)

Trials by Status

enrolling_by_invitation125%

terminated125%

recruiting250%

Recent Activity

2 active trials

Showing 4 of 4

enrolling_by_invitationphase_3

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

NCT07181135

recruiting

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

NCT06278207

terminatedphase_2

Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT

NCT06818305

recruitingphase_4

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

NCT07026539

Clinical Trials (4)

Showing 4 of 4 trials

NCT07181135Phase 3

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

Enrolling By Invitation

NCT06278207

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

Recruiting

NCT06818305Phase 2

Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT

Terminated

NCT07026539Phase 4

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Recruiting

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4